Published in Arch Gen Psychiatry on April 01, 1998
Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol (2007) 3.06
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. Int J Neuropsychopharmacol (2009) 2.33
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl) (2003) 2.28
Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism. Subst Use Misuse (2010) 1.39
Psychiatric safety of ketamine in psychopharmacology research. Psychopharmacology (Berl) (2007) 1.22
Glutamatergic targets for new alcohol medications. Psychopharmacology (Berl) (2013) 1.10
Intravenous ethanol infusion decreases human cortical γ-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 tesla. Biol Psychiatry (2011) 1.04
Acute effects of memantine in combination with alcohol in moderate drinkers. Psychopharmacology (Berl) (2003) 1.01
Clinical predictors of ketamine response in treatment-resistant major depression. J Clin Psychiatry (2014) 1.00
Ethanol-like effects of thiopental and ketamine in healthy humans. J Psychopharmacol (2008) 0.97
Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response study. Psychopharmacology (Berl) (2004) 0.96
Interactions among positions in the third and fourth membrane-associated domains at the intersubunit interface of the N-methyl-D-aspartate receptor forming sites of alcohol action. J Biol Chem (2012) 0.96
How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective. Alcohol Res Health (2008) 0.96
Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression. Bipolar Disord (2012) 0.95
N-methyl-D-aspartate receptor subunit expression in adult and adolescent brain following chronic ethanol exposure. Neuroscience (2010) 0.93
Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence. Neuropsychopharmacology (2011) 0.93
The safety of studies with intravenous Δ⁹-tetrahydrocannabinol in humans, with case histories. Psychopharmacology (Berl) (2011) 0.92
Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence. Psychopharmacology (Berl) (2004) 0.90
Behavioral effects of ketamine and toxic interactions with psychostimulants. BMC Neurosci (2006) 0.89
Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence. Neuropsychopharmacology (2010) 0.89
mTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring rats. Behav Brain Res (2013) 0.88
Alterations in ethanol-induced behaviors and consumption in knock-in mice expressing ethanol-resistant NMDA receptors. PLoS One (2013) 0.86
Pharmacological approaches to reducing craving in patients with alcohol use disorders. CNS Drugs (2014) 0.86
Greater vulnerability to the amnestic effects of ketamine in males. Psychopharmacology (Berl) (2006) 0.84
NMDA receptor antagonism: escalation of aggressive behavior in alcohol-drinking mice. Psychopharmacology (Berl) (2012) 0.82
Dextromethorphan challenge in alcohol-dependent patients and controls. Arch Gen Psychiatry (2000) 0.82
Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine. Psychopharmacology (Berl) (2005) 0.82
Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity? World J Biol Psychiatry (2013) 0.81
Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal-induced seizures and delirium tremens. Eur Arch Psychiatry Clin Neurosci (2004) 0.81
Metaplastic effects of subanesthetic ketamine on CA1 hippocampal function. Neuropharmacology (2014) 0.81
D-amino acid aberrations in cerebrospinal fluid and plasma of smokers. Neuropsychopharmacology (2013) 0.81
Chronic intermittent ethanol exposure produces persistent anxiety in adolescent and adult rats. Alcohol Clin Exp Res (2015) 0.80
Molecular basis of alcoholism. Handb Clin Neurol (2014) 0.78
Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy. Front Psychiatry (2015) 0.77
Memantine fails to facilitate partial cigarette deprivation in smokers--no role of Memantine in the treatment of nicotine dependency? J Neural Transm (Vienna) (2006) 0.76
Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive-Like Behavior During Forced Abstinence From Alcohol Drinking. Neuropsychopharmacology (2016) 0.76
Repeated ketamine administration alters N-methyl-D-aspartic acid receptor subunit gene expression: implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans. Exp Biol Med (Maywood) (2014) 0.76
Alcohol Triggers Reemergence of Ketamine-Like Experience in a Ketamine Ex-User. J Clin Psychopharmacol (2017) 0.75
Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective. F1000Res (2017) 0.75
A proof-of-concept investigation into ketamine as a pharmacological treatment for alcohol dependence: study protocol for a randomised controlled trial. Trials (2017) 0.75
Subjective Effects of Thiopental in Young Adults with and without a Family History of Alcoholism. J Addict Res Ther (2012) 0.75
Intersubunit interactions at putative sites of ethanol action in the M3 and M4 domains of the NMDA receptor GluN1 and GluN2B subunits. Br J Pharmacol (2016) 0.75
Ketamine - A Multifaceted Drug. Transl Perioper Pain Med (2015) 0.75
Do specific NMDA receptor subunits act as gateways for addictive behaviors? Genes Brain Behav (2016) 0.75
The development of a Clinician-Administered PTSD Scale. J Trauma Stress (1995) 22.71
The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry (1989) 16.61
Antidepressant effects of ketamine in depressed patients. Biol Psychiatry (2000) 10.91
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry (1994) 8.88
The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry (1989) 6.80
Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. EMBO J (1983) 5.93
MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry (1995) 5.34
Consistency of memory for combat-related traumatic events in veterans of Operation Desert Storm. Am J Psychiatry (1997) 5.13
Hippocampal volume reduction in major depression. Am J Psychiatry (2000) 5.04
Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene. EMBO J (1985) 3.68
Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry (1990) 3.57
Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc Natl Acad Sci U S A (1983) 3.40
Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse--a preliminary report. Biol Psychiatry (1997) 3.39
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A (1996) 3.28
The cellular neurobiology of depression. Nat Med (2001) 3.19
Reactivity to alcohol-related stimuli in the laboratory and in the field: predictors of craving in treated alcoholics. Addiction (2000) 3.14
Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress (1998) 3.07
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry (2002) 3.01
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry (2000) 2.92
Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry (1993) 2.89
Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry (1999) 2.78
Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: a positron emission tomography study. Biol Psychiatry (1999) 2.62
Internal validity of Project MATCH treatments: discriminability and integrity. J Consult Clin Psychol (1998) 2.56
Neural correlates of memories of childhood sexual abuse in women with and without posttraumatic stress disorder. Am J Psychiatry (1999) 2.35
Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry (1998) 2.30
Effects of early adverse experiences on brain structure and function: clinical implications. Biol Psychiatry (2000) 2.27
Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry (1997) 2.22
Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry (1991) 2.17
Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans. Am J Psychiatry (1993) 2.16
Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors. Proc Natl Acad Sci U S A (1982) 2.16
Ecological momentary assessment (EMA) with treated alcoholics: methodological problems and potential solutions. Health Psychol (1998) 2.05
Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects. Am J Psychiatry (1994) 2.04
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry (1998) 2.03
Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry (1999) 1.97
Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse (1996) 1.97
Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. Am J Psychiatry (1996) 1.87
Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr Top Microbiol Immunol (1990) 1.86
Deficits in short-term memory in posttraumatic stress disorder. Am J Psychiatry (1993) 1.81
Expression of multiple homeobox genes within diverse mammalian haemopoietic lineages. EMBO J (1988) 1.79
Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT. J Nucl Med (1995) 1.77
Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse (1996) 1.75
Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum (2000) 1.72
Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol (1995) 1.70
Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry (1989) 1.66
N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc. EMBO J (1989) 1.65
Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. Am J Psychiatry (1997) 1.59
Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry (1990) 1.56
Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry (1993) 1.56
Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab Dispos (2000) 1.56
SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med (1995) 1.56
Hereditary factors in sleepwalking and night terrors. Br J Psychiatry (1980) 1.54
Dissociation and posttraumatic stress disorder in Vietnam combat veterans. Am J Psychiatry (1992) 1.52
Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology (1997) 1.50
Reactivity to alcohol-related cues: physiological and subjective responses in alcoholics and nonproblem drinkers. J Stud Alcohol (1985) 1.50
Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder. Arch Gen Psychiatry (1989) 1.49
Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol Psychiatry (2000) 1.49
Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study. Arch Gen Psychiatry (1989) 1.47
Variant (6 ; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin kappa gene but far from the myc oncogene. Nature (1985) 1.45
A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy. J Clin Psychopharmacol (1991) 1.45
Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res (1996) 1.43
Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. Arch Gen Psychiatry (2001) 1.43
Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects. Am J Psychiatry (1991) 1.43
The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry (1996) 1.43
Cortisol response to a cognitive stress challenge in posttraumatic stress disorder (PTSD) related to childhood abuse. Psychoneuroendocrinology (2003) 1.41
Rapid detoxification from opioid dependence. Am J Psychiatry (1989) 1.40
Fear-potentiated startle in posttraumatic stress disorder. Biol Psychiatry (1995) 1.38
A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry (2000) 1.37
Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost. Am J Psychiatry (1999) 1.34
Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions. Biol Psychiatry (2000) 1.33
Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol (2007) 1.33
An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene. EMBO J (1990) 1.32
Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci (1983) 1.32
Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Arch Gen Psychiatry (1997) 1.31
Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography. Br J Ophthalmol (2007) 1.28
Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry (1984) 1.28
The psychobiological basis of posttraumatic stress disorder. Mol Psychiatry (1996) 1.28
Deficits in short-term memory in adult survivors of childhood abuse. Psychiatry Res (1995) 1.27
Matching alcoholics to coping skills or interactional therapies: posttreatment results. J Consult Clin Psychol (1989) 1.26
NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv Rev Psychiatry (1999) 1.26
Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated "voices". Biol Psychiatry (1999) 1.25
Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry (1999) 1.25
[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology (1996) 1.24
Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse (1997) 1.23
Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. J Nucl Med (1998) 1.22
Compliance with treatment and follow-up protocols in project MATCH: predictors and relationship to outcome. Alcohol Clin Exp Res (1998) 1.22
Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab (1994) 1.21
Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry (1992) 1.21
Psychobiological mechanisms of resilience: relevance to prevention and treatment of stress-related psychopathology. Dev Psychopathol (2007) 1.20
Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy. Arch Gen Psychiatry (1982) 1.20
Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry (2000) 1.20
Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry (1999) 1.20
Reactivity to alcohol cues and induced moods in alcoholics. Addict Behav (1990) 1.19
Hormone profiles in humans experiencing military survival training. Biol Psychiatry (2000) 1.19
Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine (2001) 1.19
Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. Arch Gen Psychiatry (1981) 1.17
Interactive effects of subanesthetic ketamine and haloperidol in healthy humans. Psychopharmacology (Berl) (1999) 1.17